In the last decade, the human microbiota has been extensively studied, as a result, new insights about host-microbiota interactions have surfaced revealing the effect of this interaction on human health. Scientists have learned that dysbiosis plays an important role in a series of human ailments including chronic gastrointestinal disease, metabolic syndrome, immunity and neurological diseases. However, there is a need to define gut inflammatory biomarkers. A biomarker is a biological molecule that can predict a clinically relevant endpoint or intermediate outcome, which should be quantifiably measured. The use of well-established clinical biomarkers is easier and less expensive than direct measurement of the final clinical endpoint. They can be used in disease screening, diagnosis, characterization, and monitoring; as prognostic indicators; and for developing individualized therapeutic interventions.
The goal of this Research Topic is to investigate measurement tools and applications of gut inflammatory disease biomarkers with potential application in disease screening, diagnosis, characterization, and monitoring; as prognostic indicators; and for developing individualized therapeutic interventions. We particularly welcome contributions focused on describing reliable measurements based on biomarkers to confidently assess the microbial gut function and its correlated pathologies.
In the last decade, the human microbiota has been extensively studied, as a result, new insights about host-microbiota interactions have surfaced revealing the effect of this interaction on human health. Scientists have learned that dysbiosis plays an important role in a series of human ailments including chronic gastrointestinal disease, metabolic syndrome, immunity and neurological diseases. However, there is a need to define gut inflammatory biomarkers. A biomarker is a biological molecule that can predict a clinically relevant endpoint or intermediate outcome, which should be quantifiably measured. The use of well-established clinical biomarkers is easier and less expensive than direct measurement of the final clinical endpoint. They can be used in disease screening, diagnosis, characterization, and monitoring; as prognostic indicators; and for developing individualized therapeutic interventions.
The goal of this Research Topic is to investigate measurement tools and applications of gut inflammatory disease biomarkers with potential application in disease screening, diagnosis, characterization, and monitoring; as prognostic indicators; and for developing individualized therapeutic interventions. We particularly welcome contributions focused on describing reliable measurements based on biomarkers to confidently assess the microbial gut function and its correlated pathologies.